Edwards Lifesciences Corporation Stock
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
04:00:02 2026-11-19 pm EST
|
5-day change | 1st Jan Change | ||
| 103.88 USD | -1.28% |
|
-1.82% | +21.85% |
| Nov. 19 | Leerink Partners Adjusts Price Target on Edwards Lifesciences to $116 From $112 | MT |
| Nov. 16 | Wells Fargo Adjusts Price Target on Edwards Lifesciences to $121 From $113 | MT |
| Market Cap | 60.51B 55.13B 51.03B 46.16B 86.59B 5,651B 90.63B 617B 245B 3,054B 227B 222B 9,673B | P/E 2026 * |
44.8x | P/E 2027 * | 31.9x |
|---|---|---|---|---|---|
| Enterprise Value | 57.01B 51.94B 48.08B 43.49B 81.59B 5,324B 85.39B 581B 231B 2,877B 214B 209B 9,113B | EV / Sales 2026 * |
8.37x | EV / Sales 2027 * | 7.41x |
| Free-Float |
86.54% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| EW | Delayed | |
| EW | Real-time | ||
| EW * | End-of-day quote | ||
| EWL | Real-time | ||
| EWL | Delayed | ||
| EWL | Real-time | ||
| EWL | Delayed | ||
| EWL | Delayed | ||
| EWLS | End-of-day quote | ||
| 1EW | End-of-day quote | ||
| EW | Delayed | ||
| EW | Delayed | ||
| 0REN | Real-time | ||
| Real-time |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | -1.28% | ||
| 1 week | -1.82% | ||
| Current month | +12.90% | ||
| 1 month | +19.95% | ||
| 3 months | +14.18% | ||
| 6 months | +26.08% | ||
| Current year | +21.85% |
| 1 week | 103.07 | 108 | |
| 1 month | 87.06 | 108 | |
| Current year | 74.66 | 108 | |
| 1 year | 74.66 | 108 | |
| 3 years | 58.93 | 108 | |
| 5 years | 58.93 | 131.73 | |
| 10 years | 27.04 | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 2023-05-10 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 2026-05-28 |
| Chief Tech/Sci/R&D Officer | 51 | 2025-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 2024-05-06 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 2015-02-09 |
| Director/Board Member | 58 | 2023-05-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/8/26 | Exercice | Executive/Senior Manager | 1,857 | 0.0003% | ||
| 9/14/26 | Tax | Executive/Senior Manager | -568 | 0.0001% | ||
| 9/13/26 | Tax | Controller/Auditor | -253 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.28% | -1.82% | +23.61% | +55.28% | 60.51B | ||
| -0.58% | -4.04% | +19.57% | +47.67% | 257B | ||
| -0.45% | -3.29% | +0.91% | +9.52% | 161B | ||
| -3.26% | -9.41% | -25.52% | +33.40% | 146B | ||
| -1.49% | -4.74% | -56.67% | -20.89% | 63.26B | ||
| -0.05% | +0.69% | +5.41% | -12.43% | 53.46B | ||
| -1.12% | -0.91% | +21.90% | +54.96% | 49.99B | ||
| -5.15% | -13.73% | -3.95% | +48.93% | 44.88B | ||
| -2.06% | -3.06% | +21.20% | +74.31% | 45.81B | ||
| -2.12% | -0.86% | +15.31% | +12.18% | 37.83B | ||
| Average | -0.95% | -2.93% | +2.18% | +30.29% | 92B | |
| Weighted average by Cap. | -0.77% | -3.74% | +2.23% | +31.34% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.81B 6.2B 5.74B 5.2B 9.75B 636B 10.2B 69.43B 27.54B 344B 25.55B 25.01B 1,089B | 7.48B 6.82B 6.31B 5.71B 10.71B 699B 11.2B 76.26B 30.25B 377B 28.06B 27.47B 1,196B |
| Net income | 1.34B 1.23B 1.13B 1.03B 1.92B 126B 2.01B 13.71B 5.44B 67.86B 5.04B 4.94B 215B | 1.86B 1.69B 1.57B 1.42B 2.66B 173B 2.78B 18.93B 7.51B 93.71B 6.97B 6.82B 297B |
| Net Debt | -3.5B -3.19B -2.95B -2.67B -5.01B -327B -5.24B -35.69B -14.16B -177B -13.13B -12.86B -560B | -5.08B -4.62B -4.28B -3.87B -7.26B -474B -7.6B -51.74B -20.52B -256B -19.04B -18.64B -811B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-19 | $103.88 | -1.28% | 3,656,478 |
| 26-11-18 | $105.23 | -0.19% | 3,923,271 |
| 26-11-17 | $105.43 | -1.57% | 4,272,484 |
| 26-11-16 | $107.11 | -0.04% | 4,544,597 |
| 26-11-13 | $107.15 | +1.28% | 3,822,379 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
















